Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
Paloma Montero‐Escribano, Jorge Matías‐Guiu, Patricia Gómez‐Iglesias, J. Porta‐Etessam, Vanesa Pytel, Jordi A. Matías‐Guiu
Topics & Concepts
MedicineOcrelizumabImmunosuppressionMultiple sclerosisCoronavirus disease 2019 (COVID-19)DiseasePediatricsInternal medicineImmunologyRituximabLymphomaInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19